Adjuvants for Leishmania vaccines: from models to clinical application

Two million new cases of leishmaniasis occur every year, with the cutaneous leishmaniasis (CL) presentation accounting for approximately two-thirds of all cases. Despite the high incidence rates and geographic expansion of the disease, CL remains a neglected tropical disease without effective interv...

Descripción completa

Detalles Bibliográficos
Autores principales: Raman, Vanitha S., Duthie, Malcolm S., Fox, Christopher B., Matlashewski, Greg, Reed, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371596/
https://www.ncbi.nlm.nih.gov/pubmed/22701453
http://dx.doi.org/10.3389/fimmu.2012.00144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371596/
https://www.ncbi.nlm.nih.gov/pubmed/22701453
http://dx.doi.org/10.3389/fimmu.2012.00144

Ejemplares similares